Search Medical Condition
Please enter condition
Please choose location

Ningbo City, Zhejiang Provienc, China Clinical Trials

A listing of Ningbo City, Zhejiang Provienc, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (13) clinical trials

PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor

A total of 20 patients may be enrolled over a period of 1-2 years.

Phase

0.0 miles

Learn More »

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

A total of 40 patients may be enrolled over a period of 1-2 years.

Phase

0.0 miles

Learn More »

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

A total of 40 patients may be enrolled over a period of 1-2 years.

Phase

0.0 miles

Learn More »

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

A total of 40 patients may be enrolled over a period of 1-2 years.

Phase

0.0 miles

Learn More »

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China

In the study, 500 advanced NSCLC patients will be recruited. All the patients will receive biopsy genotype assay and circultating tumor DNA (ctDNA) liquid biopsy. Patients who carry actionable EGFR mutation, ROS1 fusion, ALK fusion or MET exon 14 skipping mutation will receive TKI treatment according to guidelines. During the ...

Phase N/A

0.0 miles

Learn More »